How is pediatric coronavirus disease 2019 (COVID-19) treated?

Updated: Oct 10, 2021
  • Author: Ayesha Mirza, MD; Chief Editor: David J Cennimo, MD, FAAP, FACP, FIDSA, AAHIVS  more...
  • Print


Treatment consists mainly of supportive care, including oxygen therapy in children with hypoxia.

As of October 22, 2020, remdesivir, an antiviral agent, is the only drug approved for treatment of COVID-19. It is indicated for treatment of COVID-19 disease in hospitalized adults and children aged 12 years and older who weigh at least 40 kg. [7, 8]  An emergency use authorization (EUA) remains in place to treat pediatric patients weighing 3.5 kg to less than 40 kg or children younger than 12 years who weigh at least 3.5 kg. [9]  Several vaccines are in late stage phase 3 trials.

Please see Coronavirus Disease 2019 (COVID-19) for continually updated clinical guidance concerning COVID-19 and Treatment of Coronavirus Disease 2019 (COVID-19): Investigational Drugs and Other Therapies for updated drug information. Health care personnel are also referred to Medscape’s Novel Coronavirus Resource Center for the latest news, perspective, and resources.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!